Exelixis Clinical Site #34

Madrid 28041

0 studies enrolling now · 3 studies all time

What they study most

Colorectal Cancer, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer, Neoplasm Malignant, Non-Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma

Studies at this site

• Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma — Running, not enrolling
• Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma — Running, not enrolling
• A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors — Running, not enrolling